Dear undergraduate and taught postgraduate students
I hope that you are well. The academic year is coming to an end and most of you have finished your exams by now. Before you start your well-deserved break from the University of Cape Town (UCT) I need to remind you of the date of an important academic appeal process that you might need to use.
3 January 2022 is the deadline for submitting an appeal to continue to study if you have not met the readmission requirements. I know you want to switch off from university matters, but please keep this date in mind, as well as the dates for registration for the 2022 academic year.
Once the exam results are out, the Faculty Examination Committees (FECs) will meet in December to evaluate the progress of every student against the standards for the programme in which they are registered. If a student has not met the minimum criteria, the FECs will determine whether to grant a concession to continue the programme of study, or to deny the student permission to register next year.
An academic standing at the end of 2021 of ‘not eligible to continue’ or ‘eligible to continue if SUPP/DE passed’ means that you are not permitted to renew your registration in 2022, as you have not met the minimum academic requirements to do so. If you are deemed ineligible but want to continue to study, you must appeal by 3 January 2022.
If you do not appeal by the 3 January deadline and you later fail your supplementary or deferred exams, it will be too late to receive and consider your appeal in time for the start of the first semester in 2022.
The dean of your faculty will send you more details about this process. This communication is intended to flag the importance of the 3 January deadline should you need to submit an appeal.
I would like to take this opportunity to congratulate you for your hard work during 2021. I wish you a peaceful and restful break with your loved ones.
Associate Professor Lis Lange
Deputy Vice-Chancellor: Teaching and Learning
Read previous communications:
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Please view the republishing articles page for more information.